已收盤 05-22 16:00:00 美东时间
-0.010
-0.58%
InMed agrees to merge with Mentari Therapeutics to advance migraine drug candidates backed by $290 million in financing.
05-19 22:05
Canadian pharmaceutical company InMed Pharmaceuticals (INM) added ~170% in the premarket on Tuesday after announcing an all-stock merger agreement with migraine drug developer Mentari Therapeutics to ...
05-19 20:51
Upon consummation of the transaction contemplated by the Agreement, the combined entity will operate as Mentari Therapeutics and trade on the Nasdaq Capital Market under a new ticker symbol. Mentari's parallel lead
05-19 20:07
InMed Pharmaceuticals ( ($INM) ) just unveiled an announcement. On May 6, 2026,...
05-07 18:52
InMed Pharmaceuticals press release (INM): Q3 GAAP EPS of -$0.73. As of March 31, 2026, the Company's cash, cash equivalents and short-term investments were $5.2 million, which compares to $10.8 milli...
05-07 06:08
Qualcomm shares rose 10.6% in pre-market trading after reporting better-than-expected Q2 results. Other gainers include ABTS, AKAN, VSME, OSRH, AREB, VIAV, PI, INM, and MRAM.
04-30 17:26
An update from InMed Pharmaceuticals ( ($INM) ) is now available. On April 21 a...
04-28 06:56
InMed Pharmaceuticals ( ($INM) ) has issued an announcement. InMed Pharmaceutic...
04-04 05:00
InMed Pharmaceuticals (INM) received a notice from Nasdaq for failing the $1 minimum bid price requirement. The deficiency follows shares trading below $1.00 for 30 consecutive trading days (Feb 11–Ma...
03-28 05:12
InMed Pharmaceuticals ( ($INM) ) has issued an announcement. On March 23, 2026,...
03-23 19:58